Press release
Cancer Cachexia Market Poised for 4.7% CAGR Growth, Fueled by Rising Therapeutic Innovations - Analysis by TMR
The global cancer cachexia market is poised for significant growth, driven by advancements in therapeutics, increasing awareness, and strong government support. Valued at US$ 2.2 billion in 2022, the market is projected to grow at a CAGR of 4.7% from 2023 to 2031, reaching US$ 3.6 billion by the end of 2031. With research in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) gaining momentum and supportive therapeutic guidelines being implemented worldwide, the industry is undergoing rapid transformation.Gain an understanding of key findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15482
Market Overview
Cancer cachexia is a multifactorial syndrome characterized by skeletal muscle loss, anorexia, and metabolic dysfunction. It significantly impacts the quality of life and survival rates of cancer patients. Despite the availability of nutritional supplements, they alone are insufficient to counteract the wasting effects of the disease, necessitating aggressive research into alternative treatments.
Market Size and Growth
The global cancer cachexia market is expanding due to increased research efforts and regulatory support. The market was valued at US$ 2.2 billion in 2022 and is expected to reach US$ 3.6 billion by 2031. The steady growth is attributed to the rise in the prevalence of cancer-related cachexia, increasing patient awareness, and emerging treatment modalities. The increasing use of NSAIDs and other novel therapeutics in clinical trials is expected to bolster market progress.
Market Segmentation
The cancer cachexia market is segmented based on therapeutics, mechanism of action, and distribution channels. Therapeutic options include progestogens, corticosteroids, combination therapies, and others. Mechanisms of action involve appetite stimulators, weight loss stabilizers, and additional treatment pathways. Distribution channels include hospital stores, retail pharmacy stores, and online pharmacies.
Preview crucial insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=15482
Regional Analysis
North America led the market in 2022 due to increased awareness programs and a higher number of pipeline drugs in late-stage clinical trials. Europe is also witnessing growth, with progestogens emerging as the preferred treatment. Asia Pacific is expected to experience rapid expansion due to a large undiagnosed patient base, improved healthcare infrastructure, and increased government initiatives to enhance cancer care access.
Market Drivers and Challenges
Several factors are driving the cancer cachexia market forward. Increased research in NSAID therapeutics, supportive regulatory guidelines, and advances in oncology treatment options are some of the primary growth drivers. However, challenges such as the complex pathophysiology of the disease and the absence of a universally accepted treatment limit market growth. Side effects associated with corticosteroids and progestins also pose hurdles in effective treatment adoption.
Market Trends
Emerging trends in the cancer cachexia market include a shift toward combination therapies integrating pharmaceutical, dietary, and psychological interventions. NSAIDs are gaining prominence due to their anti-inflammatory benefits. There is also a rise in clinical trials exploring novel agents that target specific pathways such as muscular anabolism, inflammation, and appetite stimulation. Regulatory agencies are working to streamline clinical testing processes to expedite the availability of new treatments.
Competitive Landscape
The global cancer cachexia market is highly competitive, with major pharmaceutical companies investing heavily in research and development. Key players include Aeterna Zentaris Inc., Alder BioPharmaceuticals Inc., Aphios Corporation, Eli Lilly and Company, GTx Inc., Helsinn Group, Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, and XBiotech, Inc. Strategic collaborations and product launches are shaping the market dynamics, with companies focusing on expanding their global presence.
Buy this Premium Research Report for exclusive, in-depth insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=15482<ype=S
Future Outlook
The future of the cancer cachexia market looks promising, with increased investments in research and favorable regulatory landscapes. Advances in targeted therapies, coupled with heightened awareness and improved patient access to care, are expected to drive market growth. The introduction of innovative drugs and combination treatment approaches will further expand market opportunities.
More Trending Reports by Transparency Market Research -
Medical Rehabilitation Services Market: https://www.transparencymarketresearch.com/medical-rehabilitation-services-market.html
Polycystic Ovarian Syndrome Treatment Market: https://www.transparencymarketresearch.com/polycystic-ovarian-syndrome-treatment-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Cachexia Market Poised for 4.7% CAGR Growth, Fueled by Rising Therapeutic Innovations - Analysis by TMR here
News-ID: 3914408 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…